-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on Agios Pharmaceuticals, Raises Price Target to $50

Benzinga·09/21/2026 17:40:10
Listen to the news
B of A Securities analyst Alec Stranahan maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Buy and raises the price target from $46 to $50.